Effect of immunosuppression on gene expression in the HSV-1 latently infected mouse trigeminal ganglion

Shiro Higaki1, Bryan M Gebhardt, Walter J Lukiw

  • 1Department of Ophthalmology, LSU Eye Center, New Orleans, Louisiana 70112, USA.

Abstract

Insights

Immunosuppressive drugs altered gene expression in mouse trigeminal ganglia during latent herpes simplex virus (HSV)-1 infection. These changes may be crucial for ocular HSV-1 recurrence.

Area of Science:

  • Virology
  • Immunology
  • Neuroscience

Background:

  • Herpes simplex virus (HSV)-1 establishes lifelong latency in sensory neurons, primarily the trigeminal ganglia (TGs).
  • HSV-1 reactivation, often triggered by immunosuppression, can lead to recurrent disease, particularly ocular infections.

Purpose of the Study:

  • To investigate gene expression changes in mouse TGs during latent HSV-1 infection following treatment with immunosuppressive drugs (cyclophosphamide and dexamethasone).
  • To identify genes potentially involved in HSV-1 reactivation induced by immunosuppression.

Main Methods:

  • Mice were infected with HSV-1 (strain McKrae) and treated with cyclophosphamide and dexamethasone to induce reactivation.
  • Gene expression analysis was performed on TGs using microarray and semiquantitative RT-PCR.
  • Four experimental groups were analyzed: uninfected/untreated, uninfected/treated, infected/untreated, and infected/treated.

Main Results:

  • Immunosuppressive drugs increased expression of calpactin 1 light chain and GNAS in uninfected mice.
  • In latently infected mice, ten genes showed increased expression (including PTGER4, IPF1, cyclin D2, ErbB2) and eight genes showed decreased expression (including decorin, transcription factor AP-1, MAPK3) after drug treatment.
  • RT-PCR results corroborated microarray findings.

Conclusions:

  • Alterations in specific gene expressions, particularly in the prostaglandin pathway, transcription factors, and cell cycle enzymes, are linked to HSV-1 reactivation under immunosuppression.
  • These identified genes are potential key players in the mechanisms underlying ocular HSV-1 recurrence.